programme, the government agency has announced. The addition took effect on March 27 and increased the number of conditions covered to 24.

ADHD: The Active Pharmaceutical Ingredient (API) Methylphenidate is now covered for individuals of all ages diagnosed with ADHD. The NHF subsidy for the Concerta 18 milligram tablet is $174.38.

Cervical Cancer: Subsidies are now available for eight APIs used in treatment, including Bevacizumab, Carboplatin, Cisplatin, Gemcitabine, Filgrastim, Paclitaxel injections, as well as Dexamethasone and Metoclopramide tablets. The available subsidies range from $2.64 for a Dexamethasone-PMS 0.5mg tablet to $96,000 for a Bevacizumab 400mg/16ml injection. (Jamaica Gleaner)